Chestnut (Castanea crenata) inner shell extract inhibits development of hepatic steatosis in C57BL/6 mice fed a high-fat diet

Food Chemistry

Volumn 121, Issue 2, 2010, Pages 437-442

  Noh, Jung Ran ^a   Kim, Yong Hoon ^a   Gang, Gil Tae ^a   Yang, Keum Jin ^a   Lee, Hyun Sun ^a   Nguyen, Phi Hung ^b   Oh, Won Keun ^b   Song, Kyung Sik ^c   Lee, Chul Ho ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chosun University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Chestnut inner shell; Hepatic lipid; Hepatic steatosis; Lipid metabolism

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ACETYL COENZYME A CARBOXYLASE; CARNITINE PALMITOYLTRANSFERASE; CASTANEA CRENATA EXTRACT; CHOLESTEROL ACYLTRANSFERASE; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; PLANT EXTRACT; SCOPARONE; SCOPOLETIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTANEA CRENATA; CHESTNUT; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY LIVER; FOOD INTAKE; GENE EXPRESSION; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE;

CASTANEA CRENATA; MUS;

EID: 77049092274     PISSN: 03088146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodchem.2009.12.061     Document Type: Article

References (24)

1. Anstee Q.M., and Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. International Journal of Experimental Pathology 87 (2006) 1-16
2. Bellentani S., Saccoccio G., Masutti F., Crocè L.S., Brandi G., Sasso F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Annals of Internal Medicine 132 (2000) 112-117
3. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 37 (1959) 911-917
4. Browning J.D., and Horton J.D. Molecular mediators of hepatic steatosis and liver injury. The Journal of Clinical Investigation 114 (2004) 147-152
5. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 40 (2004) 1387-1395
6. Calliste C.A., Trouillas P., Allais D.P., and Duroux J.L. Castanea sativa Mill. Leaves as new sources of natural antioxidant: An electronic spin resonance study. Journal of Agricultural and Food Chemistry 53 (2005) 282-288
7. Chi Y.S., Heo M.Y., Chung J.H., Jo B.K., and Kim H.P. Effects of the chestnut inner shell extract on the expression of adhesion molecules, fibronectin and vitronectin, of skin fibroblasts in culture. Archives of Pharmacal Research 25 (2002) 469-474
8. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. The Journal of Clinical Investigation 109 (2002) 1125-1131
9. Huang H.C., Huang Y.L., Chang J.H., Chen C.C., and Lee Y.T. Possible mechanism of immunosuppressive effect of scoparone (6,7-dimethoxycoumarin). European Journal of Pharmacology 217 (1992) 143-148
10. Huang H.C., Lee C.R., Weng Y.L., and Lee Y.T. Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. European Journal of Pharmacology 218 (1992) 123-128
11. Huh, Z. (1966). Tang-aek, In Z. Huh (Ed.), Dong-Eu-Bo-Gam. Namsandang, Seoul. 1613; 1160 (translated version).
12. Hulcher F.H., and Oleson W.H. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. Journal of Lipid Research 14 (1973) 625-631
13. Krause B.R., and Bocan T.M.A. ACAT inhibitors: Physiologic mechanisms for hypolipidemic and anti-atherosclerotic activities in experimental animals. In: Ruffolo Jr. R.R., and Hollinger M.A. (Eds). Inflammation mediators and pathways (1995), CRC Press, Boca Raton, FL 173-198
14. Liu R., Sun Q., Sun A., and Cui J. Isolation and purification of coumarin compounds from Cortex fraxinus by high-speed counter-current chromatography. Journal of Chromatography A 1072 (2005) 195-199
15. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Buqianesi E., Lenzi M., et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 50 (2001) 1844-1850
16. Markwell M.A., McGroarty E.J., Bieber L.L., and Tolbert N.E. The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. The Journal of Biological Chemistry 248 (1973) 3426-3432
17. Nepokroeff C.M., Lakshmanan M.R., and Porter J.W. Fatty acid synthase from rat liver. Methods in Enzymology 35 (1975) 37-44
18. Nomura H., Kashiwagi S., Hayashi J., Kajiyama W., Tani S., and Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Japanese Journal of Medicine 27 (1988) 142-149
19. Paulauskis J.D., and Sul H.S. Hormonal regulation of mouse fatty acid synthase gene transcription in liver. The Journal of Biological Chemistry 264 (1989) 574-577
20. Ribeiro B., Rangel J., Valentão P.X.C., Andrade P.B., Pereira J.A., Bölke H., et al. Organic acids in two portuguese chestnut (Castanea sativa Miller) varieties. Food Chemistry 100 (2007) 504-508
21. Sgro C., and Escousse A. Side effects of fibrates (except liver and muscle). Therapie 46 (1991) 351-354
22. Varela-Rey M., Embade N., Ariz U., Lu S.C., Mato J.M., and Martinez-Chantar M.L. Non-alcoholic steatohepatitis and animal models: Understanding the human disease. The International Journal of Biochemistry and Cell Biology 41 (2009) 969-976
23. Yang M.J., Kim M.G., Lim S.J., Ann H.S., and Ahn R.M. Inhibitory effects of water-acetone extracts of chestnut inner shell, pine needle and hop on the melanin biosynthesis. The Pharmaceutical Society of Korea 43 (1999) 494-501
24. Zuoqi D., Yue D., Haiping H., Rong P., Xiujuan Y., and Zhengtao W. Anti-inflammatory effects of scopoletin and underlying mechanisms. Pharmaceutical Biology 46 (2008) 854-860